Published on:

Johnson & Johnson Hit with $70 Million Verdict in Baby Powder Ovarian Cancer Case

A Missouri jury concluded that Deborah Giannecchini’s use of Johnson & Johnson baby powder for more than 40 years caused her ovarian cancer.

This verdict follows verdicts of $72 million and $55 million in other cases. In all 3 cases, the plaintiff’s alleged that Johnson & Johnson knew that studies linked talc in its baby powder and Shower-to-Shower products to ovarian cancer in women. They further alleged that despite this knowledge, Johnson & Johnson continued to market the products to women and failed to put warning labels on their products.

Gloria Ristesund of Sioux Falls, SD was diagnosed in 2011 with cancer after continuous use of Johnson & Johnson feminine products that contained talc for over a 40-year span. In May of 2016, a St. Louis jury awarded her $55 million after talc was found in her ovarian tissue following her hysterectomy.

Jacqueline Fox of Birmingham, AL, used Johnson & Johnson’s baby powder and Johnson & Johnson’s Shower to Shower for over 35 years. She was diagnosed with ovarian cancer in 2013 and died in 2015 at the age of 62 before her case was able to get to trial. A St. Louis jury awarded her family $72 million in February of 2016.

Nationally, Johnson & Johnson has been accused in roughly 1,800 lawsuits in state and federal court of ignoring studies linking its baby powder and Shower-to-Shower talc products to ovarian cancer and failing to warn customers about the risk.

If you or a loved one has used a talcum-powder product and as a result are or have experienced negative or unwanted outcomes contact the Naumes Law Group for a free consultation at 844-826-8445 or online at

Contact Information